Oncology Institute (TOI) Non Operating Income (2020 - 2025)

Oncology Institute (TOI) has disclosed Non Operating Income for 6 consecutive years, with $14.4 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Non Operating Income rose 738.45% year-over-year to $14.4 million, compared with a TTM value of -$2.4 million through Sep 2025, down 43.61%, and an annual FY2024 reading of -$4.5 million, down 545.6% over the prior year.
  • Non Operating Income was $14.4 million for Q3 2025 at Oncology Institute, up from -$14.9 million in the prior quarter.
  • Across five years, Non Operating Income topped out at $69.2 million in Q4 2022 and bottomed at -$14.9 million in Q2 2025.
  • Average Non Operating Income over 5 years is $4.0 million, with a median of -$80000.0 recorded in 2021.
  • The sharpest move saw Non Operating Income skyrocketed 86635.0% in 2022, then crashed 9230.56% in 2023.
  • Year by year, Non Operating Income stood at -$80000.0 in 2021, then surged by 86635.0% to $69.2 million in 2022, then plummeted by 97.69% to $1.6 million in 2023, then crashed by 178.21% to -$1.3 million in 2024, then skyrocketed by 1251.56% to $14.4 million in 2025.
  • Business Quant data shows Non Operating Income for TOI at $14.4 million in Q3 2025, -$14.9 million in Q2 2025, and -$752000.0 in Q1 2025.